TrialCardiovascular therapeutics2020

Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol.

Roland Gal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.